Download Diapositiva 1

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Management strategies in the quest for the comprehensive
health care: the experience of the Specialized Pharmaceutical
Services Component
Authors*: Schneiders RE, Zimmermann IR, de Araujo LRM, Alexandre RF, do
Nascimento Jr. JM, Gadelha CAG.
Background
The Brazilian public health system ensures universal, equitable and
comprehensive access to health technologies, including medicines. The clinical
conditions treated in the Specialized Pharmaceutical Services Component (SPSC)
are defined in the Clinical Protocols and Therapeutic Guidelines (CPTD) in the
form of lines of care.
Objectives
To describe the experience and results
of the SPSC with its particular
strategies in the quest for the
comprehensive health care.
Methods
Focused on the SPSC’s issues, we did a
retrospective data analysis related to its
management
strategies
for
the
pharmaceutical services in the public
health system in the last two years.
Reduction of expenses and growth of the amount of
medicines distributed
2009
2011
Substances purchased centrally by the Ministry
of Health
Results
As a strategy to increase medicines
access and optimization of resource
allocation, the Ministry of Health (MoH)
expanded the amount of centralized
procurement medicines, from 13 to 46
products. This deed was focused on
those medicines with a concentrated
market. As a consequence, this action
allowed average resource savings of
33% in two years, with 96% increase in
the number of units distributed in the
same period.
Discussion
The SPSC was designed in 2010 for the budgetary resources optimization and to
expand access to medicines for diseases that require complex health services or
high-cost medicines. Within this Component, the municipalities provide the firstline treatment and the states finance the medicines for refractory to first-line
treatment. Further, the MoH finances the medicines with greatest global impact or
to situations refractory to other treatments, by the centralized procurement or by
financial transfers.
Implications
The purchasing power of the MoH, together with the appropriate selection of
medicines, definition of lines of care, organization of services within the CPTD's
recommendations are strategies that allowed expansion of access to medicines.
*Brazilian Ministry of Health
E-mail: [email protected]
Ministry of
Health